Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Personalized Medicine From Genomics and Bioinformatics Highlighted at UCSF Genetics Symposium

Published: Thursday, November 15, 2012
Last Updated: Thursday, November 15, 2012
Bookmark and Share
Personalized medicine advances arising from genetic discoveries were the primary focus of wide-ranging presentations at the UCSF Institute for Human Genetics 2012 Symposium.

Speakers described clinical research that has resulted in the identification of gene mutations that often drive deadly breast cancers in black populations; explained how rare mutations responsible for devastating developmental defects in infants can now be discovered in studies of just a handful of individuals from affected families; offered a preview of results expected to emerge from studies of genes and environment in hundreds of thousands of patients through a Kaiser Permanente-UCSF project; and described technical advances that continue to increase scientists’ ability to identify links between DNA and disease.

All the speakers “are at the cutting edge of applying genomics and informatics to precision medicine,” said the institute’s director Neil Risch, MD, referring to an emerging trend in medicine in which treatment is tailored to the patient through a more precise diagnosis of disease.

At UCSF — a crucible of biotechnology and home to Nobel laureates who identified a role for the mutation of normal genes in cancer — major new initiatives are underway in clinical genetics and bioinformatics, Risch said.

The symposium led off with geneticist Eddy Rubin, MD, PhD, whose presentation demonstrated that genetic studies are being applied to human problems that extend even beyond the realm of medicine.

Rubin – a scientist who oversaw the sequencing and analysis of 13 percent of the human genome as part of the original Human Genome Project – has taken his research from studying abnormalities in DNA “enhancers” that may contribute to disease susceptibility or birth defects, to cutting global greenhouse gas emissions by manipulating gut microbes in sheep.

Early in his career, Rubin completed a medical genetics fellowship under the late Charles Epstein, MD, a founding director of the UCSF Institute for Human Genetics and a driving force behind medical genetics becoming an accredited medical specialty. Rubin was featured at the symposium as the named 2012 Charles J. and Lois B. Epstein Visiting Professor at UCSF.

Rubin, director of the Department of Energy’s Joint Genome Institute and director of the Genome Sciences Division at Lawrence Berkeley National Laboratory, is a pioneer in exploring DNA beyond genes, which until recently was a poorly understood realm that may nonetheless prove to be key to understanding fundamental aspects of biology and disease.

Researchers were for decades focused on DNA that encodes proteins – the genes. But the sequencing and analysis of the genome has revealed that genes account for less than 2 percent of the DNA on the 46 human chromosomes. Within the universe of DNA, the stuff beyond the genes is comparable to the poorly understood dark matter of the cosmos.

DNA 'Enhancers' Guide Development

Rather than working under the lamppost where the genes are, Rubin explores DNA within these dark regions of the chromosomes. He focuses on bits of DNA called “enhancers,” which play an important role in determining how much protein is made from a gene at a particular time and place within an organism – with great implications for how a creature develops.

Rubin wondered: Could abnormal enhancers or unusual variations in specific enhancers be playing a role in disease susceptibility or birth defects?

Some enhancers are similar across many organisms, while others are more specific to humans or to other species, Rubin said. Within the cell’s DNA, the enhancers often are nowhere near the genes they affect, but Rubin has developed new ways to find them.

Enhancers switch on and off as an organism develops, and some are uniquely activated within particular tissues. Many enhancers are the same in different species, “conserved” through the course of evolution.

But the enhancers that switch on later in development are more likely to be unique to that species. “Early in development, we see very conserved enhancers, but later on during development we see enhancers that are not conserved,” Rubin said.

Thus the developing human heart, which forms early during embryogenesis, shares many enhancers with the developing hearts of other species. Brains, which form later, share fewer enhancers across species.

Working with mice, Rubin has identified 4,400 enhancers involved in shaping the face and the bones of the head and found that some abnormal enhancer DNA appears to play a role in facial abnormalities. “We’re seeing subtle effects … with many variants causing small effects,” he said.

Sheep Flatulence and Global Warming

At the DOE Joint Genome Institute, Rubin has begun to devote more of his research effort to the study of global greenhouse gases, specifically the contributions from livestock such as cows and sheep. These barnyard beasts harbor gut microbes that produce methane while helping the sheep to digest grass and other sources of cellulose.

As countries with large populations become wealthier, their citizens not only aspire to drive more cars and own more appliances, they also want to eat more meat, Rubin said, which is likely to lead to yet more greenhouse gas production as more of these domestic animals are raised to meet the growing demand.

In New Zealand, Rubin said, “They do believe in climate change, and they are putting in place a carbon tax, and they’re going to be charging their sheep farmers. So the sheep farmers are very interested in how the sheep produce methane and whether they can mitigate it at all.”

Rubin and his New Zealand colleagues studied 23 age- and size-matched members of a flock of sheep raised in the same pasture. The gut, or more precisely the “rumen” of a sheep contains massive amounts of bacteria, protozoa and fungi that ferment cellulose in grass and convert it into nutrients for the sheep. But sheep also house another type of microbe called Archaea. Archaea produce methane, which the sheep burp and fart out, Rubin said.

Genetic analysis permitted the researchers to figure out why methane emissions varied among sheep and to determine how Archaea might be a suitable target of efforts to lower methane release.

Rubin and colleagues did not find differences in the numbers of methane-producing microbes between the high-methane and low-methane producing sheep, but they did find that the methane-producing microbes within high-methane-emitting sheep were better at making methane, as evidenced by the increased activation of genes involved in the biochemical steps of methane production.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

RNA-Binding Proteins Role in ALS Revealed
Researchers describe how damage to RNA-binding protein contributes to ALS, isolating a possible therapeutic target.
Monday, October 24, 2016
Zika Virus Infection Alters Human and Viral RNA
Researchers have discovered that Zika infections results in human and viral genetic modification.
Monday, October 24, 2016
Genome Sequencing May Help Avert Banana Armageddon
Researchers at the University of California, Davis, and in the Netherlands have discovered how three fungal diseases have evolved into a lethal threat to the world’s bananas.
Friday, August 12, 2016
‘Human-on-a-Chip’ Could Replace Animal Testing
Researchers are developing a “human-on-a-chip,” a miniature external replication of the human body, integrating biology and engineering with a combination of microfluidics and multi-electrode arrays.
Monday, June 13, 2016
Unveiling the Complexity of Mysterious Protein Folding
Imagine trying to reverse engineer a car when all you have is a finished product or a box full of parts — no instructions.
Wednesday, June 01, 2016
Study Identifies How Brain Connects Memories Across Time
UCLA Neuroscientists have boost ability of aging brain to recapture links between related memories.
Tuesday, May 31, 2016
Transcription Factor Isoforms Implicated in Colon Diseases
UC Riverside study explains how distribution of two forms of a transcription factor in the colon influence risk of disease.
Thursday, May 19, 2016
An E.coli Detector May be in Your Hands Soon
Hand-held device that can be used to detect a variety of pathogens—including foodborne pathogens like E. coli—at all stages in the food supply chain, from fields to restaurants may be available soon.
Monday, May 16, 2016
Fructose Alters Hundreds of Brain Genes
UCLA scientists report that diet rich in omega-3 fatty acids can reverse the damage.
Tuesday, April 26, 2016
Study Yields the Key to Effective Personalized Medicine
A team of UCLA bioengineers and surgeons has taken a major step toward making personalized medicine a reality.
Monday, April 11, 2016
Tracking RNA in Live Cells
Technique may open doors to new treatments for many conditions, from cancer to autism.
Friday, March 18, 2016
Cat Stem Cell Therapy Gives Humans Hope
By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives.
Monday, February 08, 2016
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Monday, February 08, 2016
Toxic Pollutants Found in Fish Across the World's Oceans
Scripps researchers' analysis shows highly variable pollutant concentrations in fish meat.
Friday, January 29, 2016
Key Enzyme in Pierce’s Disease Grapevine Damage Uncovered
UC Davis plant scientists have identified an enzyme that appears to play a key role in the insect-transmitted bacterial infection of grapevines with Pierce’s disease, which annually costs California’s grape and wine industries more than $100 million.
Wednesday, January 13, 2016
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
BGI Sequences Gingko Tree, Revealing Large, Highly Repetitive Genome
Researchers at BGI have sequenced the more than 10-gigabase ginkgo genome to find a high number of repetitive sequences as well as a number of gene clusters that appear to be involved in defense mechanisms.
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
Accelerating the Detection of Foodborne Bacterial Outbreaks
The speed of diagnosis of foodborne bacterial outbreaks could be improved by a new technique developed by researchers at the Georgia Institute of Technology.
Making Personalized Medicine a Reality
Groundbreaking technique developed at McMaster University is helping to pave the way for advances in personalized medicine.
Scientists Identify Unique Genomic Features in Testicular Cancer
The findings may shed light on factors in other cancers that influence their sensitivity to chemotherapy.
Top 10 Life Science Innovations of 2016
2016 has seen the release of some truly innovative products. To help you digest these developments, The Scientist have listed their top picks for the year.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!